Search results
Results from the WOW.Com Content Network
FRAX (fracture risk assessment tool) is a diagnostic tool used to evaluate the 10-year probability of bone fracture risk. It was developed by the University of Sheffield . [ 1 ]
The Framingham Risk Score is a sex-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. The Framingham Risk Score was first developed based on data obtained from the Framingham Heart Study, to estimate the 10-year risk of developing coronary heart disease. [1]
A person's risk can be measured with the University of Sheffield's FRAX calculator—which includes many clinical risk factors, including prior fragility fracture, use of glucocorticoids, heavy smoking, excess alcohol intake, rheumatoid arthritis, history of parental hip fracture, chronic renal and liver disease, chronic respiratory disease ...
Race adjustment, also known as race-correction, [1] [2] is the calculating of a result which takes into account race. [1] It is commonly used in medical algorithms in several specialties, including cardiology, nephrology, urology, obstetrics, endocrinology, oncology and respiratory medicine. [1]
The Index now features a fundraising benchmark calculator that will allow users to easily chart their own results against the Index, historical data to provide a fuller view of charitable giving ...
Recognized calculators include FRAX, [24] the Garvan FRC calculator and QFracture as well as the open access FREM tool. [25] The FRAX tool can also be applied in a modification adapted to routinely collected health data. [26] The term "established osteoporosis" is used when a broken bone due to osteoporosis has occurred. [27]
The Antonio Madero B. Stock Index From January 2008 to February 2009, if you bought shares in companies when Antonio Madero B. joined the board, and sold them when he left, you would have a -71.3 percent return on your investment, compared to a -47.9 percent return from the S&P 500.
The trabecular bone score is a measure of bone texture correlated with bone microarchitecture and a marker for the risk of osteoporosis.Introduced in 2008, [1] its main projected use is alongside measures of bone density in better predicting fracture risk in people with metabolic bone problems.